-
[Illinois] CNST 2012: Gold Nanoparticles In, On, and Around Cells
Online Presentations | 02 Jun 2013 | Contributor(s):: Cathy Murphy
…
-
[Illinois] CNST 2012: Making Mid-Infrared Photonics Nano with Plasmonics and Metamaterials
Online Presentations | 02 Jun 2013 | Contributor(s):: Daniel Wasserman
CNST Workshop 2012 May 2–3, 2012 Showcasing University of Illinois research in bionanotechnology/nanomedicine, nanoelectronics/nanophotonics, and nanomaterials/nanomanufacturing, leading to cross-campus and industry collaborations National Center for Supercomputing Applications Micro and...
-
[Illinois] B3SI 2012: International Collaboration Panel
Online Presentations | 17 May 2013 | Contributor(s):: Hao-Ming Hsiao, Irfan S. Ahmad, Nai-Jen Harry Chang, Taher A. Saif, Xin Tang, Hsiang-Yu Angie Wang
…
-
[Illinois] B3SI 2012: Circumventing Barriers to Nanoparticle Delivery In Vivo
Online Presentations | 02 Aug 2012 | Contributor(s):: Susan E. Clare
…
-
[Illinois] Cancer Community Symposium 2012: T Cell Receptors For Potential Cancer Immunotherapy Applications: Single Chain T Cell Receptors Circumvent Mispairing with Endogenous TCR and Mediate T Cell Activity
Online Presentations | 09 May 2012 | Contributor(s):: David H. Aggen
To improve the immune response to cancer, gene therapy with tumor-specific T cell-receptors (TCRs) provides an attractive approach to effectively arm patients T cells for tumor cell destruction. A high-affinity TCR specific for an antigenic peptide-major histocompatibility complex (pepMHC) can be...
-
[Illinois] Cancer Community Symposium 2012: Panel Discussion
Online Presentations | 09 May 2012
Please join us for a panel discussion on the social impact of cancer and how it affects patients, providers, clinicians, and researchers alike. We are fortunate to feature Leslie Hammersmith (moderator), Jennifer Smith, and Patience Anders from the local Young Survival Coalition, as well as an...
-
Application of Dynamic Light Scattering in the Physicochemical Characterization of Natural and Engineered Nanoparticles
Online Presentations | 20 Apr 2012 | Contributor(s):: Trisha Eustaquio
This presentation will highlight the use of dynamic light scattering (DLS), which measures the hydrodynamic size of nanoparticles in suspension, in characterizing specific examples of engineered and natural nanoparticles. In terms of engineered nanoparticles, the role of nanoparticle size in...
-
The Importance of Zeta Potential for Drug/Gene Delivery in Nanomedicine
Online Presentations | 11 Apr 2012 | Contributor(s):: James Leary
Keynote Address
-
Finding a Needle in a Haystack: Nanobarcoding for Single Nanoparticle Detection in in vitro and ex vivo Nanomedical Biodistribution Studies
Online Presentations | 14 Feb 2012 | Contributor(s):: Trisha Eustaquio
Determination of the fate of administered nanoparticles in a biological system, or nanoparticle biodistribution, is critical in evaluating a nanoparticle formulation for nanomedical purposes. Unlike their small-molecule drug antecedents, nanoparticles pose unique challenges in the design of...
-
Illinois 2011 NanoBiophotonics Summer School: Dr. Naash - Research
Online Presentations | 21 Jan 2012 | Contributor(s):: Muna Naash
-
Illinois 2011 NanoBiophotonics Summer School: Dr. Naash - Collaboration
Online Presentations | 21 Jan 2012 | Contributor(s):: Muna Naash
-
Illinois Nano EP Seminar Series Spring 2011: Interfacing Engineering, Biology, and Medicine at the Micro and Nano Scale
Online Presentations | 13 Dec 2011 | Contributor(s):: Rashid Bashir
In this talk, we will present an overviewof our work in Silicon-Based BioMEMS and Bionanotechnology and discuss the state of the art and thefuture challenges and opportunities. We will review a range of projects in our group focused towardsdeveloping rapid detection of biological entities and...
-
KIST/PU Nanostructured Heparin Derivatives as an Angiogenesis Inhibitor
Online Presentations | 07 Dec 2011 | Contributor(s):: Youngro Byun
Although low molecular weight heparin (LMWH) has been known to regulate angiogenesis, tumor growth and metastasis, the administration of heparin for treating cancer is limited in clinical application due to its unsatisfactory therapeutic effects and a strong anticoagulant activity, which induces...
-
KIST/PU The Professor’s Challenge: To commercialize or not, that is the question?
Online Presentations | 06 Dec 2011 | Contributor(s):: J. Paul Robinson
Outline:Outline the Professors DilemmaShow what the normal criteria for research project direction isDiscuss the Corporate perspectiveDiscuss an example of failed innovationDemonstrate how time can impact an innovative ideaConclusions
-
KIST/PU Designing a Research Program Around Unmet Clinical Needs
Online Presentations | 06 Dec 2011 | Contributor(s):: Alyssa Panitch
-
KIST/PU Theragnosis – A New Paradigm of Personalized Medicine
Online Presentations | 06 Dec 2011 | Contributor(s):: Ick Chan Kwon
Companion Diagnosis, based on pharmacogenomics, has been recognized as one of most important key representatives of personalized medicine. However, Companion Diagnosis does not provide any clues in developing new ways of therapeutics but it only provides a best choice of drugs based on given...
-
Illinois BioNanotechnology Seminar Series Fall 2011: Precisely Size Controlled Drug-silica Nanoconjugate for Cancer Therapy
Online Presentations | 05 Dec 2011 | Contributor(s):: Li Tang
Drug delivery nanomedicine, exemplified by micelles and nanoparticles roughly in the size range of 1-200 nm, have attracted much interest in the past 2-3 decades as alternative modalities for cancer treatment. The size of these drug delivery vehicles has been strongly correlated with their in...
-
Illinois BioNanotechnology Seminar Series Fall 2011: Directed Blood Vessel Growth Using an Angiogenic Microfiber/Microparticle Composite Patch
Online Presentations | 05 Dec 2011 | Contributor(s):: Ross J DeVolder
Therapeutic angiogenesis has emerged as a promising strategy to treat various acute and chronic vascular diseases, and to enhance tissue repair and regeneration. Common revascularization therapies include the administration of angiogenic factors, such as vascular endothelial growth factor (VEGF)....
-
Illinois BioNanotechnology Seminar Series Fall 2011: Deconvolving Stiffness in MEMS Pedestal Cell Mass Measurements
Online Presentations | 05 Dec 2011 | Contributor(s):: Elise Corbin
The complex relationships between a cell's behavior and the physical properties of both itself and its environment have long been of interest. Specifically, the understanding the mechanisms through which a cell's physical properties influence cell growth, cell differentiation, cell cycle...
-
BME 695L Special Lecture 4: Atomic Force Microscopy (AFM) for Nanomedical Systems (cells and nanoparticles)
Online Presentations | 02 Dec 2011 | Contributor(s):: Helen McNally
Guest lecturer: Helen McNally